Max Healthcare Institute Ltd
NSE:MAXHEALTH
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
601.65
1 079.9
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd
Cash & Cash Equivalents
Max Healthcare Institute Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Max Healthcare Institute Ltd
NSE:MAXHEALTH
|
Cash & Cash Equivalents
₹13.7B
|
CAGR 3-Years
30%
|
CAGR 5-Years
160%
|
CAGR 10-Years
N/A
|
|
|
Krishna Institute of Medical Sciences Ltd
NSE:KIMS
|
Cash & Cash Equivalents
₹468.9m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
Cash & Cash Equivalents
₹5.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
F
|
Fortis Healthcare Ltd
NSE:FORTIS
|
Cash & Cash Equivalents
₹6B
|
CAGR 3-Years
13%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
9%
|
|
|
Narayana Hrudayalaya Ltd
NSE:NH
|
Cash & Cash Equivalents
₹4.7B
|
CAGR 3-Years
46%
|
CAGR 5-Years
53%
|
CAGR 10-Years
N/A
|
|
|
G
|
Global Health Ltd
NSE:MEDANTA
|
Cash & Cash Equivalents
₹7.7B
|
CAGR 3-Years
123%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Max Healthcare Institute Ltd
Glance View
Max Healthcare Institute Ltd. is a leading player in India’s rapidly evolving healthcare sector, renowned for its commitment to high-quality medical care and advanced technology. Founded in 2000, the company operates a robust network of multi-specialty hospitals and clinics, catering to a diverse patient population across urban and semi-urban regions. With a focus on patient-centric services, Max Healthcare has garnered a stellar reputation for its expertise in critical care, cardiology, oncology, and orthopedics. The institution is backed by a strong management team with extensive experience in healthcare and business, positioning it well to navigate the challenges of the industry while capitalizing on the growing demand for quality healthcare services in India. For investors, Max Healthcare represents an attractive opportunity, given the company’s strategic initiatives to expand its footprint and enhance service quality. As the healthcare landscape in India grows, propelled by rising income levels and an increasing focus on health and wellness, Max Healthcare's expansion plans—including new hospitals and technological advancements—suggest a promising trajectory for revenue growth. The company's innovative approach, combined with a solid operational framework, not only assures patients of comprehensive care but also creates value for shareholders. By investing in Max Healthcare, stakeholders can position themselves to benefit from the burgeoning healthcare market in India, characterized by increasing consumer spending on health services and a favorable regulatory environment.
See Also
What is Max Healthcare Institute Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
13.7B
INR
Based on the financial report for Mar 31, 2024, Max Healthcare Institute Ltd's Cash & Cash Equivalents amounts to 13.7B INR.
What is Max Healthcare Institute Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
160%
Over the last year, the Cash & Cash Equivalents growth was 0%. The average annual Cash & Cash Equivalents growth rates for Max Healthcare Institute Ltd have been 30% over the past three years , 160% over the past five years .
You don't have any saved screeners yet
